Transgene Biotek Limited (BOM:526139)
2.750
-0.010 (-0.36%)
At close: Mar 10, 2026
Transgene Biotek Revenue
Transgene Biotek had revenue of 545.00K INR in the quarter ending December 31, 2025, a decrease of -28.76%. This brings the company's revenue in the last twelve months to 2.33M, up 1.73% year-over-year. In the fiscal year ending March 31, 2025, Transgene Biotek had annual revenue of 2.61M with 10.98% growth.
Revenue (ttm)
2.33M
Revenue Growth
+1.73%
P/S Ratio
89.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
208.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.61M | 258.00K | 10.98% |
| Mar 31, 2024 | 2.35M | 1.80M | 326.32% |
| Mar 31, 2023 | 551.00K | -315.95K | -36.44% |
| Mar 31, 2022 | 866.95K | -828.55K | -48.87% |
| Mar 31, 2021 | 1.70M | 1.66M | 4,642.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Balurghat Technologies | 1.14B |
| Onesource Industries and Ventures | 990.40M |
| Konark Synthetic | 505.16M |
| Soni Medicare | 267.83M |
| KCL Infra Projects | 237.06M |
| KJMC Financial Services | 60.18M |
| Epic Energy | 53.70M |
| Pro Clb Global | 3.15M |